GFAP and Alexander disease: Given our findings that pSer13-GFAP is enriched in the most aggressive form of AxD, monitoring the levels of this phospho-epitope (in addition to total GFAP) in AxD patient cerebrospinal fluid or blood may provide added sensitivity for disease activity (Jany et al., 2015).